Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Acute Kidney Injury (AKI) Epidemiology Forecast, 2027

Research and Markets
Posted on: 25 Oct 18
Acute Kidney Injury (AKI) Epidemiology Forecast, 2027

PR Newswire

DUBLIN, Oct 25, 2018

DUBLIN, Oct 25, 2018 /PRNewswire/ --

The "Acute Kidney Injury (AKI) - Epidemiology Forecast" report has been added to's offering.

Acute Kidney Injury (AKI) - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Acute Kidney Injury in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The Acute Kidney Injury (AKI) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Acute Kidney Injury are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total incident cases, discharge diagnosed cases, stage-wise discharge diagnosed cases, risk factor associated AKI cases and renal transplantation associated delayed graft function cases) scenario of Acute Kidney Injury (AKI) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, total incident population of Acute Kidney Injury (AKI) in 7 major markets was found to be 1,516,635 in 2016.

Report Scope

  • The report covers detailed overview of Acute Kidney Injury explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Acute Kidney Injury in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the AKI epidemiology by Stage-wise discharge diagnosed Cases i.e., Stage I, Stage II, and Stage III and risk factor associated AKI i.e. coexisting conditions and acute hospital-related factors in 7MM

Key strengths

  • 10 Year Forecast of Acute Kidney Injury epidemiology
  • 7MM Coverage
  • Total Incident Cases of AKI
  • Discharge Diagnosed cases of AKI
  • Discharge Diagnosed cases according to segmentation: Stage-wise discharge diagnosed i.e., Stage I, Stage II, and Stage III
  • Risk Factors Associated AKI Cases

Key Topics Covered:

1. Key Insights

2. Acute Kidney Injury Market: Overview at a Glance
2.1. Market Share Distribution of AKI in 2017
2.2. Market Share Distribution of AKI in 2027

3. Acute Kidney Injury (AKI): Disease Background and Overview
3.1. Introduction
3.2. Symptoms
3.3. Types of Acute Kidney Injury
3.4. Stages Classification
3.5. Risk Factors
3.6. Etiology
3.7. Pathophysiology
3.8. Biomarkers
3.9. Diagnosis

4. Epidemiology and Patient Population
4.1. Key Findings
4.2. 7MM Total Incident Patient Population of AKI
4.3. 7MM Total Discharge Diagnosed Population of AKI

5. Country Wise-Epidemiology of Acute Kidney Injury
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Incident Cases of Acute Kidney Injury in the US
5.1.3. Discharge Diagnosed Cases of Acute Kidney Injury in the US
5.1.4. Stage-Wise Discharged Diagnosed Cases of Acute Kidney Injury in the US
5.1.5. Risk Factor Associated Acute Kidney Injury Cases in the US
5.1.6. Renal Transplantation Associated Delayed Graft Function Cases in the US
5.2. EU5
5.3. Germany
5.4. France
5.5. Italy
5.6. Spain
5.7. United Kingdom
5.8. Japan

6. Market Drivers

7. Market Barriers

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


View original content:

SOURCE Research and Markets

PR Newswire

Last updated on: 25/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.